
|Articles|April 1, 2003
OHTS changing way ocular hypertension is treated
Baltimore-Treatment of people with ocular hypertension without a diagnosis of glau-coma has been poorly understood, but there is no doubt that the Ocular Hypertension Treatment Study (OHTS) has brought the field a lot farther.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
First patient treated in ViaLase’s IDE trial
2
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
3
PainReform launches development plan for OcuRing-K, readies phase 2 trial
4
Formosa Pharmaceuticals and Rxilient sign licensing and commercialization agreement for APP13007
5















































.png)


